September 25, 2016 4:52 AM ET

Pharmaceuticals

Company Overview of QR Pharma, Inc.

Company Overview

QR Pharma, Inc. develops drugs for the treatment of mild cognitive impairment, Alzheimer's, Parkinson's, and Down Syndrome diseases. It offers Posiphen compound for mild cognitive impairment and early stage Alzheimer's disease; and Bisnorcymserine compound that inhibits amyloid formation and prevents the progression of the Alzheimer's disease. QR Pharma, Inc. was founded in 2008 and is based in Berwyn, Pennsylvania.

1055 Westlakes Drive

Suite 300

Berwyn, PA 19312

United States

Founded in 2008

Phone:

610-727-3913

Fax:

610-727-4001

Key Executives for QR Pharma, Inc.

Founder, Chief Executive Officer, President and Director
Vice President of Operations
Vice President of Formulation
Strategic Advisor and Director
Compensation as of Fiscal Year 2016.

QR Pharma, Inc. Key Developments

QR Pharma, Inc. Presents at The 23rd Annual NewsMakers in the Biotech Industry Conference, Sep-09-2016

QR Pharma, Inc. Presents at The 23rd Annual NewsMakers in the Biotech Industry Conference, Sep-09-2016. Venue: Millennium Broadway Hotel & Conference Center, New York, New York, United States. Presentation Date(s): Sep-09-2016.

QR Pharma Begins Collaboration on Posiphen and Huntington’s Disease

QR Pharma, Inc. announced a new collaborative research agreement with The Rockefeller University aimed at developing a treatment for Huntington's disease (HD). The collaboration will focus on preclinical research involving QRâ s lead drug candidate, Posiphen ®. Investigators at Rockefeller will conduct experiments in stem cell culture models of HD to determine, if Posiphen lowers the levels of the toxic huntingtin protein in these cells, if it promotes differentiation into neuronal cells and, if it prolongs the cell life of the HD cells. Results from the collaboration could lead to clinical studies in HD patients.

QR Pharma, Inc. Appoints Management

QR Pharma, Inc. announced the election of Mr. Michael Hoffman as Chairman of the Board of Directors and Mr. Dhesh Govender as Director. Mr. M. B. Hoffman is a Partner of Riverstone Holdings LLC. Dhesh S.K. Govender is currently CEO and Founder of Tara Immuno-Oncology LLC.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact QR Pharma, Inc., please visit www.qrpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.